Dyne Therapeutics' FDA decision on rostudirsen, a treatment for exon
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What the company said
“PDUFA target action date of January 21, 2027”
More on DYN and the FDA calendar
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Use this page
How to cite
Breakaway, Dyne Therapeutics' FDA decision on rostudirsen, a treatment for exon, Nov 10, 2026, getbreakaway.com/biotech/DYN-rostudirsen
Journalists: email support@getbreakaway.com for the data behind this page.